Clinical Trials Browser

Has results × Recurrence × daratumumab × Clear all

NCT03450057 2024-03-29

DARE

Phase 2 Completed

38 enrolled 16 charts

Multiple Myeloma, Recurrence

NCT03679624 2023-10-23

Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia

Phase 2 Terminated

1 enrolled 8 charts

Hypergammaglobulinemia, Waldenstrom Macroglobulinemia, Recurrence

NCT03000452 2018-10-16

FUSION-MM-005

Phase 2 Completed

18 enrolled 16 charts

Multiple Myeloma, Recurrence